iBio, Inc. (IBIO)

Revenue by Product

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Jun 30, 2024	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2009	Jun 30, 2008	Jun 30, 2007
Precision Antibodies	225.00K

Revenue by Geography

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Jun 30, 2024	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016	Jun 30, 2015	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2009	Jun 30, 2008	Jun 30, 2007
United States	225.00K
United States Growth	-90.56%